Fundraising Fox

Actuate Therapeutics

NASDAQ: ACTU

Fort Worth, US · Founded 2015 · Delaware corporation · 4 known investors

actuatetherapeutics.com ↗

Clinical-stage therapeutics company focusing on high-impact cancers and inflammatory diseases.

Biotechin /actuate-therapeutics-inc.@ActuateThera

Founders & leadership

DS
Daniel SchmittExecutive Officer, Director
AM
Andrew MazarExecutive Officer
PL
Paul LytleExecutive Officer
LW
Leslie Wayne Kreis, Jr.Director, Promoter
TT
Todd ThomsonDirector
RS
Roger SawhneyDirector
JK
Jason KeyesDirector
AG
Aaron G.L. FletcherDirector
AR
Amy RonnebergDirector
DZ
Daniel ZabrowskiDirector

Investors · 4

Illinois VenturesChampaign
Kairos Venture Investments, LlcBeverly Hills · $150K – $20M
BiosreportedFort Worth
Bios PartnersreportedFort Worthvia Leslie W. Kreis, Jr. · board

Reported raises · per SEC filings

Form D private placements
▶$4.7MraisedJul 2025 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Todd ThomsonDirector
  • Daniel SchmittExecutive Officer, Director
  • Paul LytleExecutive Officer
  • Roger SawhneyDirector
  • Andrew MazarExecutive Officer
  • Amy RonnebergDirector
  • Daniel ZabrowskiDirector
  • Jason KeyesDirector
  • Aaron G.L. FletcherDirector
Offering amount
$9.3M
Amount sold
$4.7M
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MofferedApr 2025 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel SchmittExecutive Officer, Director
  • Andrew MazarExecutive Officer
  • Paul LytleExecutive Officer
  • Aaron G.L. FletcherDirector
  • Daniel ZabrowskiDirector
  • Amy RonnebergDirector
  • Roger SawhneyDirector
  • Jason KeyesDirector
  • Todd ThomsonDirector
Offering amount
$50M
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedMar 2024 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Aaron FletcherDirector
  • Daniel SchmittExecutive Officer, Director
  • Leslie Kreis, Jr.Director
  • Dan ZabrowskiDirector
  • Todd ThomsonDirector
Offering amount
$5M
Amount sold
$3M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.3MraisedDec 2022 · 95 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Aaron Glenn Louis FletcherDirector
  • Leslie Wayne Kreis, Jr.Director
  • Dan ZabrowskiDirector
  • Todd ThomsonDirector
  • Daniel SchmittExecutive Officer, Director
Offering amount
$50M
Amount sold
$19.3M
Sales commissions
$1.7M
Placement agents
Newbridge Securities Corporation
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.5MraisedDec 2020 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel SchmittExecutive Officer, Director
  • Pascal KroteeDirector
  • Alex AndrianopoulosDirector
  • Leslie Wayne Kreis, Jr.Director
  • Aaron Glenn Louis FletcherDirector
Offering amount
$50M
Amount sold
$14.5M
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.5MraisedNov 2019 · 17 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel M. SchmittExecutive Officer, Director
  • AARON GLENN LOUIS FLETCHERDirector
  • LESLIE WAYNE KREIS, JR.Director
  • ALEX ANDRIANOPOULOSDirector
  • NEIL BAJPAYEEDirector
Offering amount
$6.5M
Amount sold
$6.5M
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.9MraisedMay 2019 · 21 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • DANIEL M SCHMITTExecutive Officer, Director
  • AARON GLENN LOUIS FLETCHERDirector
  • LESLIE WAYNE KREIS JR.Director
Offering amount
$24M
Amount sold
$21.9M
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedSep 2018 · 18 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • AARON GLENN LOUIS FLETCHERDirector
  • DANIEL M SCHMITTExecutive Officer, Director
  • LESLIE WAYNE KREIS JR.Director
Offering amount
$4M
Amount sold
$4M
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.